Sponsor:
Uro-1 Medical
Code:
NCT05470127
Conditions
Prostate Disease
Prostate CA
Eligibility Criteria
Sex: Male
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Prostate biopsy needle
Brief summary:
Conditions
Prostate Disease
Prostate CA
Study ID
NCT05470127
Start date
Aug 1, 2022
Status verified date
May, 2025
Completion date
Dec, 2025
Anticipated
Primary completion date
Oct, 2025
Anticipated
Eligibility Criteria
Sex: Male
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
200 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Diagnostic
Arms
experimental: SUREcore biopsy needle
active comparator: Standard of Care biopsy needle
Interventions
Prostate biopsy needle
Primary outcome measure
Central contacts
Locations
Georgia Urology
Recruiting
Cartersville, Georgia, United States, 30115
Contacts
Principal Investigator:
Jeffrey Proctor, MD
Sponsor
Uro-1 Medical
Last update posted
May 7, 2025
Last verified
May, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Uro-1 Medical on 2025-05-07.